Patents by Inventor Donald J. Graham

Donald J. Graham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8354518
    Abstract: The present invention features methods for enhancing the ability of a genotype 2b NS5B sequence to function in a replicon, for producing replicons containing a functional genotype 2b NS5B, and for using replicons to measure the ability of a compound to affect HCV replication that is sustained with the genotype 2b polymerase. Also featured is a genotype 1b NS4B adaptive mutation. The ability to produce replicons containing a functional genotype 2b NS5B is illustrated by the production of chimeric replicons based on HCV genotype 1b where substantially all the NS5B sequence is replaced with a genotype 2b NS5B.
    Type: Grant
    Filed: November 3, 2004
    Date of Patent: January 15, 2013
    Assignees: Merck Sharp & Dohme Corp., Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A.
    Inventors: Steven W. Ludmerer, Donald J. Graham, Robert L. LaFemina, Osvaldo A. Flores, Maura Pizzuti, Cinzia Traboni
  • Publication number: 20110250628
    Abstract: The present invention features methods for enhancing the ability of a genotype 2b NS5B sequence to function in a replicon, for producing replicons containing a functional genotype 2b NS5B, and for using replicons to measure the ability of a compound to affect HCV replication that is sustained with the genotype 2b polymerase. Also featured is a genotype 1b NS4B adaptive mutation. The ability to produce replicons containing a functional genotype 2b NS5B is illustrated by the production of chimeric replicons based on HCV genotype 1b where substantially all the NS5B sequence is replaced with a genotype 2b NS5B.
    Type: Application
    Filed: November 3, 2004
    Publication date: October 13, 2011
    Inventors: Steven W. Ludmerer, Donald J. Graham, Robert L. Lafemina, Osvaldo A. Flores, Maura Pizzuti, Cinzia Traboni
  • Publication number: 20100143886
    Abstract: HCV mutations emerged in chimpanzees treated with a N5B polymerase inhibitor (Compound A) or a NS3 protease inhibitor (Compound B). Short term treatment with Compound A was followed by the initial emergence of an HCV with a S282T polymerase mutation following treatment. Short term treatment with Compound B selected for HCV with a R155K or D168T protease mutation.
    Type: Application
    Filed: March 5, 2008
    Publication date: June 10, 2010
    Inventors: Steven W. Ludmerer, Donald J. Graham, David B. Olsen, Warren E. Glaab
  • Publication number: 20090203008
    Abstract: A method for measuring HCV NS3/4A activity from a HCV NS3/4A sequence, comprising obtaining and cloning the sequence into a mammalian expression vector, transiently transfecting a mammalian cell with the vector, which includes a reporter construct encoding a HCV NS3/4A cleavage site fused to a detectable label, measuring signal production from the label resulting from cleavage at the cleavage site, and measuring effects on signal production by addition of a test compound.
    Type: Application
    Filed: June 4, 2007
    Publication date: August 13, 2009
    Inventors: Steven W. Ludmerer, Donald J. Graham, David B. Olsen
  • Patent number: 7569374
    Abstract: The present invention features NS5B polypeptides from different clinically important HCV genotypes. The polypeptides can be used individually, or as part of a panel of RNA-dependent RNA polymerases, to evaluate the effectiveness of a compound to inhibit NS5B activity.
    Type: Grant
    Filed: December 17, 2007
    Date of Patent: August 4, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Donald J. Graham, Amy L. Simcoe, Steven W. Ludmerer, Osvaldo A. Flores, Robert L. LaFemina
  • Publication number: 20080187903
    Abstract: The present invention features NS5B polypeptides from different clinically important HCV genotypes. The polypeptides can be used individually, or as part of a panel of RNA-dependent RNA polymerases, to evaluate the effectiveness of a compound to inhibit NS5B activity.
    Type: Application
    Filed: December 17, 2007
    Publication date: August 7, 2008
    Inventors: Donald J. Graham, Amy L. Simcoe, Steven W. Ludmerer, Osvaldo A. Flores, Robert L. LaFemina
  • Patent number: 7329732
    Abstract: The present invention features NS5B polypeptides from different clinically important HCV genotypes. The polypeptides can be used individually, or as part of a panel of RNA-dependent RNA polymerases, to evaluate the effectiveness of a compound to inhibit NS5B activity.
    Type: Grant
    Filed: January 6, 2005
    Date of Patent: February 12, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Donald J. Graham, Amy L. Simcoe, Steven W. Ludmerer, Osvaldo A. Flores, Robert L. LaFemina
  • Patent number: 5436131
    Abstract: A chromogenic assay is described for the identification and isolation of drug-resistant HIV protease mutants. Coversely, the assay is useful to screen for new inhibitors of HIV protease, e.g., inhibitors not affected by drug-resistance of the HIV protease. This color screening assay contains a vector comprising a regulatable promoter which controls the transcription of two adjacent structural sequences, one sequence coding for HIV protease or mutant thereof, the other sequence coding for beta-galactosidase with an amino acid substrate insert cleavable by HIV protease. A library of HIV proteases is also described and is isolated in the form of a collection of such vectors, which is a color screen vector library.
    Type: Grant
    Filed: April 2, 1993
    Date of Patent: July 25, 1995
    Assignee: Merck & Co., Inc.
    Inventors: Jon H. Condra, Donald J. Graham, Leah Gotlib
  • Patent number: 4892224
    Abstract: A trash entry chute device for mounting on a top-opening trash container, which device supports and holds open a limp plastic film bag for use as a disposable liner for the container. The device comprises a chute having a flange which supports the device on the container and diverts trash into the chute, and bag support means in opposite positions on the outside surface of the chute. When a bag is supported by the device, the chute fits into the mouth of the bag, holding it open to receive trash.
    Type: Grant
    Filed: May 6, 1988
    Date of Patent: January 9, 1990
    Inventor: Donald J. Graham